INTEGRATION OF CYTOKINE RECEPTORS AND IMMUNORECEPTORS SIGNALING PATHWAYS
Project Number1R56AI087725-01
Contact PI/Project LeaderMEDZHITOV, RUSLAN
Awardee OrganizationYALE UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): The overall goal of this proposal is to characterize the mechanisms of signal integration between ITAM-containing receptor complexes and cytokine receptors that signal through the Jak-STAT pathways. ITAM-containing receptors play prominent role in all aspects of leukocyte function. Their activation usually requires tyrosine (Y) phosphorylation and therefore, depends on a 'priming signal' delivered from a Y-kinase, generally assumed to be the member of a Src family kinases (SFK). Receptor 'priming' is followed by a recruitment and activation of SH2 containing Y-kinases: Syk-72 or ZAP-70, which initiate several downstream signaling pathways. However, different ITAM-containing receptors respond to a broad variety of ligands and produce distinct biological outcomes, raising the question as to how specificity of cellular response is achieved if the same receptor uses the same signaling module under all circumstances. Emerging data, including those from our group, suggest a role for cytokine receptors and Jak kinases in priming/modulating the signals emanating from ITAM-containing receptors. Based on these findings, we propose to investigate the hypothesis that Jak kinases activated by appropriate cytokine receptors are involved in Y-phosphorylation of ITAM and ITAM-like receptors/adaptors, thereby coupling the recognition of two distinct types of signals: ligands recognized by ITAM-containing receptors and cytokines. We further hypothesize that this type of signal integration provides specificity of cellular responses, and makes them conditional upon the appropriate context defined by the cytokines produced in distinct physiological settings. We expect that the results of our investigation will provide a new model of signaling by the two major families of receptors in leukocytes: cytokine receptors and ITAM-containing immunoreceptors.
PUBLIC HEALTH RELEVANCE: Leukocyte functions are regulated by two major families of receptors: the ITAM-containing receptors and cytokine receptors. We propose to characterize the new mechanism of regulation of signaling by the two receptor families that would explain the context dependent function of leukocytes. The proposed studies will reveal new possibilities for therapeutic interventions for immune and inflammatory disorders.
Public Health Relevance Statement
Lukocyte functions are regulated by two major families of receptors: the ITAM-containing
receptors and cytokine receptors. We propose to characterize the new mechanism of regulation
of signaling by the two receptor families that would explain the context dependent function of
leukocytes. The proposed studies will reveal new possibilities for therapeutic interventions for
immune and inflammatory disorders.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
01-September-2010
Project End Date
31-August-2011
Budget Start Date
01-September-2010
Budget End Date
31-August-2011
Project Funding Information for 2010
Total Funding
$413,750
Direct Costs
$250,000
Indirect Costs
$163,750
Year
Funding IC
FY Total Cost by IC
2010
National Institute of Allergy and Infectious Diseases
$413,750
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R56AI087725-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R56AI087725-01
Patents
No Patents information available for 1R56AI087725-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R56AI087725-01
Clinical Studies
No Clinical Studies information available for 1R56AI087725-01
News and More
Related News Releases
No news release information available for 1R56AI087725-01
History
No Historical information available for 1R56AI087725-01
Similar Projects
No Similar Projects information available for 1R56AI087725-01